Dr. Mark Joseph Swierzewski, MD

Dr. Swierzewski practices at Watson Clinic in Lakeland, Florida.

Dr. Swierzewski's NPI, 1497705727, was assigned on May 10, 2006. Dr. Swierzewski graduated from Tufts University School Of Medicine in 1988. Dr. Swierzewski holds Florida license ME71165.

Dr. Swierzewski's primary practice is Watson Clinic, at 1430 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 680-7700.

Dr. Swierzewski's primary practice is Watson Clinic in Lakeland, Florida. Dr. Swierzewski is also affiliated with Viera Hospital. The medical group on file is Parrish Medical Group. Dmand AI also links Dr. Swierzewski to 1 more hospital, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swierzewski practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Swierzewski's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Swierzewski is board certified in urology by the American Board of Urology. Dmand AI has Dr. Swierzewski's licenses on file in 2 states: Florida and New York.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Swierzewski treats.

CMS data shows 2,638 Medicare services from Dr. Swierzewski across 25 procedure codes in 2024, for 1,068 Medicare patients. Medicare paid $250,767 for them.

CMS counts 1,068 Medicare patients who saw Dr. Swierzewski in 2024. The largest group is 65 to 74, with 437 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swierzewski's median patient age at 73, with 25% women.

In 2024, Dr. Swierzewski wrote 3,227 Medicare Part D claims for 1,276 patients. 96% of them were for generic drugs. CMS names the drug for 3,134 of them, across 22 drugs with 11 or more claims each, at $117,049 in total drug cost. In 2023, CMS named 3,461 claims across 23 drugs.

Dr. Swierzewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Swierzewski.

Dmand AI links Dr. Swierzewski to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 155 general payments to Dr. Swierzewski from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Coloplast Corp paid the most, $957.

Dmand AI lists 1 award for Dr. Swierzewski, most recently CMS Stage 1 2012 in 2012.

Dr. Swierzewski graduated from Tufts University School Of Medicine in 1988. Dr. Swierzewski is a member of SLS.

Dr. Swierzewski is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.